Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

Completed · Phase 2 · Has a placebo group

Conditions studied: Psoriasis

In brief

This is a Phase 2b, randomized, double blind, vehicle controlled, parallel group, multicenter study in participants with mild to moderate plaque psoriasis. The duration of study participation will be approximately 22 weeks, including up to a 6 week screening period, 12 week treatment period, and approximately 4 week follow up period. Approximately 280 participants are planned to be randomized into the study.

Key facts

Study ID

NCT03850483

Run by

Pfizer

People needed

344

Starts

2019-04-08

Expected to finish

2021-04-20

Last updated by the study team

2022-06-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• plaque psoriasis for 6 months
• PGA score mild or moderate
• body surface area (BSA) 2-15%

You may not qualify if…

• other skin conditions that would interfere with the evaluation of psoriasis
• history of herpes zoster or simplex
• Infected with Mycobacterium tuberculosis

Where it is running

• Center for Dermatology and Plastic Surgery — Scottsdale, Arizona, United States
• Burke Pharmaceutical Research — Hot Springs, Arkansas, United States
• Anaheim Clinical Trials, LLC — Anaheim, California, United States
• California Skin Institute — Anaheim, California, United States
• California Dermatology & Clinical Research Institute — Encinitas, California, United States
• First OC Dermatology — Fountain Valley, California, United States
• Clinical Science Institute — Santa Monica, California, United States
• New England Research Associates, LLC — Bridgeport, Connecticut, United States
• Dermatology Physicians of Connecticut — Shelton, Connecticut, United States
• Olympian Clinical Research — Clearwater, Florida, United States
• Accel Research Sites - DeLand Clinical Research Unit — DeLand, Florida, United States
• Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
• Renstar Medical Research — Ocala, Florida, United States
• MidState Skin Institute — Ocala, Florida, United States
• Renstar Medical Research — Ocala, Florida, United States
• Park Avenue Dermatology, PA — Orange Park, Florida, United States
• Center for Clinical Studies — Tampa, Florida, United States
• Dundee Dermatology — West Dundee, Illinois, United States
• Ds Research — Clarksville, Indiana, United States
• DS Research — Louisville, Kentucky, United States
• Meridian Clinical Research, LLC — Baton Rouge, Louisiana, United States
• MediSearch Clinical Trials — Saint Joseph, Missouri, United States
• Hassman Research Institute — Berlin, New Jersey, United States
• Psoriasis Treatment Center of Central New Jersey — East Windsor, New Jersey, United States
• Center for Dermatology and Plastic Surgery/CCT — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.